Kennedy injects uncertainty into big pharma

The US unveiled new tariffs to replace old ones, oil’s jump above $100 deepened a global bond sell-off, and thousands of supporters of the youth-led “Cockroach” movement in India continued protesting over problems in the education system. Plus, the European Central Bank held inte ...  Show more

Tesla reported its first cash burn in more than two years in the second quarter, and US oil refineries are running at full tilt as wars in the Middle East and Ukraine choke global supplies of fuels such as diesel. Plus, the UK consumer price index dropped in June, and Deutsche Ba ...  Show more

Kara and Scott discuss whether Trump will fire Fed Chair Jerome Powell, and all of the administration's efforts to distract from the Epstein scandal. Elon Musk’s Grok scores a contract with the Defense Department, and Andrew Cuomo will officially run as an independent in the NYC ...  Show more

Donald Trump prepares to pay a $175 million bond, Truth Social goes public and a date is set for the first ever criminal trial of a former president. Mike Johnson faces a motion to vacate his speakership while his House majority seems to be disappearing. Bibi Netanyahu beefs w ...

Your morning briefing, the business news you need in just 15 minutes. On today's podcast: (1) China’s central bank lowered the interest rate charged on its one-year policy loans by the most on record, kicking off a sweeping program to revive confidence in the world’s second-large ...  Show more

Episode 682: Neal and Toby talk about Trump’s newly launched “TrumpRx” program designed to make more prescription drugs affordable. Then, the federal EV tax credit has officially ended, and some believe a drastic slowdown in EV sales. Also, Amazon overhauls its hardware and some ...  Show more